TFX
TELEFLEX INCPrice
Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).
- Feb 26 Teleflex reported strong 2025 financial results with GAAP revenue up…
- May 7 Teleflex Q1 2026 adjusted EPS of $1.39 beat consensus by 14%, and pr…
- Jun 8 ▲ Piper Sandler upgrades
- Jul 2 ▲ The Federal Circuit affirmed summary judgment of noninfringement in…
- Jul 9 BMO Capital initiates
- Jul 28 UBS initiates
- Aug 6 Teleflex reported Q2 2026 adjusted EPS of $1.76, a 37.4% beat vs the…
- Aug 14 ▼ Short interest jumps 59.7% to 4.84M
- Sep 28 ▲ B of A Securities upgrades
- Nov 5 ▲ Teleflex Q3 2026 revenue of $567.8M was essentially flat YoY (+0.2%…
- Nov 5 ▲ Earnings: TFX Q3 2026 Earnings: EPS $2.63 (+36.8% vs est)
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- InstitutionsBULLISH
Q2 2026: 29 added (0 new), 18 trimmed or exited.
- AnalystsBULLISH
9 of 18 rate it Buy or better. Every target is above the price.
- Short sellersSTEADY
Short interest −3.6% to 4.07M shares. 5.9 days to cover, ≈10.3% of shares.
- TrendUPTREND
17% above its 50-day average. New closing high $157.10 on Nov 16.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| MILLENNIUM MANAGEMENT LLC | DOUBLED | $182.8M |
| GOLDMAN SACHS GROUP INC | DOUBLED | $114.8M |
| Holocene Advisors, LP | DOUBLED | $112.3M |
| NORGES BANK | ADD | $86.8M |
| JPMORGAN CHASE & CO | DOUBLED | $50.6M |
| UBS Group AG | ADD | $49.7M |
| BNP PARIBAS FINANCIAL MARKETS | DOUBLED | $38.7M |
| Quantinno Capital Management LP | DOUBLED | $20.1M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
18 analystsPrice is below the lowest target. Median implies +8%.Targets as of Nov 16, 2026.
| Date | Firm | Rating |
|---|---|---|
| Nov 9, 2026 | Truist Securities MAINTAIN | Hold |
| Nov 6, 2026 | RBC Capital MAINTAIN | Outperform |
| Nov 6, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
| Oct 14, 2026 | Truist Securities MAINTAIN | Hold |
| Sep 28, 2026 | B of A Securities UPGRADE | Buy |
| Aug 25, 2026 | Needham MAINTAIN | Buy |
Insider ledger
Form 4| Insider | Type | Value |
|---|---|---|
Salmon Sean Director Sep 8, 2026 | AWARD | 4,444 sh |
Salmon Sean Director Sep 8, 2026 | AWARD | 674 sh |
Weidman Jason R. President and CEO Jun 8, 2026 | AWARD | 53,983 sh |
Weidman Jason R. President and CEO Jun 8, 2026 | AWARD | 26,071 sh |
RANDLE STUART A Director Jun 8, 2026 | AWARD | 995 sh |
RANDLE STUART A Director Jun 8, 2026 | AWARD | 2,192 sh |
RANDLE STUART A Director Jun 8, 2026 | AWARD | 4,663 sh |
RANDLE STUART A Director Jun 7, 2026 | TAX W/H | $526.4K |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Washington
Short side
FINRA· Oct 30, 2026SecBot reports
11 filings · 2 bullish · 0 bearish · 4 mixed · 5 neutral- NEUTRAL SC 13G/ANov 16, 2026
T. Rowe Price Investment Management disclosed a 6.1% passive stake in Teleflex as of September 30, 2026, up from a prior filing. The increase is routine for a passive asset manager and does not signal activist intent.
🔒 Fresh report (last 24h), subscribers only
- BULLISH 8-KNov 5, 2026
Teleflex Q3 2026 revenue of $567.8M was essentially flat YoY (+0.2% reported, +3.0% pro forma…
The 39% adjusted EPS beat and raised guidance reflect strong margin execution and aggressive share repurchases. Watch for closing of the Acute Care/Interventional Urology divestiture by year-end…
- MIXED 8-KAug 6, 2026
Teleflex reported Q2 2026 adjusted EPS of $1.76, a 37.4% beat vs the $1.28 consensus, driven by…
The earnings beat and raised EPS guidance are positive, but the revenue guidance cut signals a slower growth trajectory for the core business. Traders should watch for execution on the Biotronik…
- BULLISH COURT-RULINGJul 2, 2026
The Federal Circuit affirmed summary judgment of noninfringement in favor of Teleflex Medical…
The complete removal of patent infringement liability for the McGrath Series 5 laryngoscope eliminates a key overhang. Traders should monitor for any petition for certiorari, though the…
All TFX filing & press-release reports (11)
- SC 13G/A reportNov 16, 2026
- 8-K reportNov 5, 2026
- 8-K reportAug 6, 2026
- COURT-RULING reportJul 2, 2026
- INST-CLUSTER reportJun 22, 2026
- 8-K reportJun 15, 2026
- 8-K reportJun 9, 2026
- 8-K reportJun 1, 2026
- 8-K reportMay 27, 2026
- 8-K reportMay 7, 2026
- 8-K reportFeb 26, 2026